Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00469729
Status:
COMPLETED
Last Update Posted:
2015-07-10
First Post:
2007-05-03
Brief Title:
Efficacy and Safety Study of StemEx to Treat Subjects With High Risk Hematologic Malignancies Following Myeloablative Therapy
Sponsor:
Gamida Cell -Teva Joint Venture Ltd
Organization:
Gamida Cell -Teva Joint Venture Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Hematologic Malignancies |
| Acute Myeloid Leukemia |
| Lymphoid Leukemia |
| Chronic Myeloid Leukemia |
| Hodgkins Disease |
| Non-Hodgkins Lymphoma |